位置:成果数据库 > 期刊 > 期刊详情页
人Tenascin—Raa454—1069多克隆抗体制备蛋白的原核表达及多克隆抗体制备
  • ISSN号:1001-9448
  • 期刊名称:《广东医学》
  • 时间:0
  • 分类:R692[医药卫生—泌尿科学;医药卫生—临床医学;医药卫生—外科学] R394[医药卫生—医学遗传学;医药卫生—基础医学]
  • 作者机构:[1]南方医科大学珠江医院神经外科,广州510282
  • 相关基金:国家自然科学基金重点项目(编号:U0632008);国家青年科学基金项目(编号:30801184);广东省科学基金资助项目(编号:2008A030201019)
中文摘要:

目的表达和纯化带多聚组氨酸(6×His)标签的人Tenascin—REGFL结构域(Tenascin-Raa454-1069)的融合蛋白,并制备相应的兔源性多克隆抗体(pAb)。方法利用PCR从PMD18-T—TNR获得Tenascin-Raa454-1069编码序列,将其亚克隆至原核表达载体pET30a(+),构建重组表达质粒pET30a(+)-Tenascin-Raa454-1069;将阳性重组质粒转化大肠杆菌,IPTG诱导表达6×His—Tenascin-Raa454-1069融合蛋白,经Ni—NTA螯合树脂纯化,纯化蛋白免疫新西兰大白兔制备多克隆抗血清,Protein A Sepharose柱纯化获得多抗,ELISA法检测抗体效价,Western blot法检测抗体特异性。结果成功构建了pET30a(+)-Tenascin-Raa454-1069原核表达载体,原核蛋白Tenascin-Raa454-1069以包涵体形式在大肠杆菌高水平表达,通过复性与亲和层析获得纯度在90%以上的融合蛋白,蛋白浓度为1600mg/L,制备的抗Tenascin-Raa454-1069多抗效价高达1:1.6×10^6,Western blot鉴定其具有良好的特异性。结论获得高纯度Tenascin-Raa454-1069蛋白并成功制备特异性pAb,为进一步研究Tenascin—R的生物学功能提供实验基础。

英文摘要:

Objective To express and purify the fusion protein of EGFL region of human Tenascin - R (hTenascin-Raa454-1069) in prokaryocytes and to prepare rabbit anti - Tenascin-Raa454-1069 polyclonal antibody (pAb). Methods The 616 bp DNA sequence of hTenascin-Raa454-1069 was obtained from PMD18 -T -TNR by PCR and subsequently inserted into pET30a( + ) plasmid to construct the prokaryotic expression plasmid pET30a( + ) -hTenascin-Raa454-1069. pET30a( + ) - hTenascin-Raa454-1069 was transformed into E. coli. The target fusion protein was expressed with the induction of Isopropyl 13 -D- 1 -thiogalactopyranoside (IPTG) and was purified by Ni^2+ -NTA affinity chromatography col- umn. The antiserum against hLINGO- 1aa76-319 was obtained from the rabbits immunized with hTenascin-Raa454-1069. The titer of pAb was determined by ELISA and the specificity of pAb was confirmed by Western blot. Results The prokaryotic expression plasmid pET30a( + ) -hTenascin-Raa454-1069was successfully constructed. The culture condition for high expression of target fusion protein was as followings: The optimal concentration of IPTG was 0.4mmol/L, the culture temperature was 37~C and the culture time was 2.5 h. The hTenascin-Raa454-1069 fusion protein was effectively expressed in E. coli as inclusion body. Soluble protein was obtained through denaturation and refolding procedure. The fusion protein was purified by Ni - NTA Resin affinity column was more than 90% purity. The anti - hLINGO - 1aa76-319 pAb was prepared by immunizing the rabbits with the purified target fusion protein. ELISA showed the titer of pAb was 1 : 1.6 × 10^6. Westeru blot analysis confirmed anti - hLINGO - 1aa76-319 pAb was of good specificity. Conclusion The fusion protein hTenascin - Raa454-1069 with high purity has been obtained and the anti - hTenascin-Raa454-1069 pAb with high titer and good specificity has been prepared. Our study facilitates further research into the molecular function of Tenascin - R.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《广东医学》
  • 北大核心期刊(2011版)
  • 主管单位:广东省卫生和计划生育委员会
  • 主办单位:广东省医学学术交流中心
  • 主编:苏焕群
  • 地址:广州市惠福西路进步里2号之6
  • 邮编:510180
  • 邮箱:gdyx1963@163.com zhuangxw@126.com
  • 电话:020-81906074 81865066
  • 国际标准刊号:ISSN:1001-9448
  • 国内统一刊号:ISSN:44-1192/R
  • 邮发代号:46-66
  • 获奖情况:
  • 中国科技论文统计源期刊,美国《化学文摘》(CA)收录期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版)
  • 被引量:70380